Unosi

• Efekti odloženog oslobađanja dimetil fumarata na MRI u faza 3 CONFIRM studiji (2015-03)

  S. Grgić, H. Miller, F. JR, P. JT, M. Hutchinson, E. Havrdova, M. Kita, C. Wheeler-Kingshott, D. Tozer, D. MacManus, T. Yousry, M. Goodsell, M. Yang, R. Zhang, V. Viglietta, K. Dawson, Efekti odloženog oslobađanja dimetil fumarata na MRI u faza 3 CONFIRM studiji, EUROPEAN JOURNAL OF NEUROLOGY, pp. 1145 - 1152, Mar, 2015

• CONFIRM Study Investigators - Placebo-controlled phase 3 study of oral BG-12 or glatiramer in muliple sclerosis (2012-10)

  F. RJ, M. DH, P. JT, H. M, H. E, K. M, Y. M, R. K, N. M, S. MT, V. V, D. K, S. Grgić, CONFIRM Study Investigators - Placebo-controlled phase 3 study of oral BG-12 or glatiramer in muliple sclerosis, NEW ENGLAND JOURNAL OF MEDICINE, Vol. 12, No. 367, pp. 1087 - 1097, Oct, 2012

• DEFINE Study Investigators - Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis (2012-10)

  G. R, K. L, A. DL, B. A, G. G, S. K, T. C, S. MT, Y. M, S. SI, D. KT, S. Grgić, DEFINE Study Investigators - Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis, NEW ENGLAND JOURNAL OF MEDICINE, Vol. 12, No. 367, pp. 1098 - 1107, Oct, 2012